Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

1.2K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

693
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
693
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

2.5K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.5K
Schizophrenia01:17

Schizophrenia

1.8K
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
1.8K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

1.2K
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
1.2K
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

956
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
956

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lymphoma accelerates T cell and tissue aging.

Cancer cell·2025
Same author

Mixed methods family-centered study of acute post-surgical pain experience in non-hispanic white and black children.

The journal of pain·2025
Same author

Evolving Role of Pharmacists in Care Coordination: A National Survey.

Therapeutic innovation & regulatory science·2018
Same author

Hepatic safety of ambrisentan alone and in combination with tadalafil: a post-hoc analysis of the AMBITION trial.

Pulmonary circulation·2018
Same author

Healthcare utilization and expenditures for United States Medicare beneficiaries with systemic vasculitis.

Seminars in arthritis and rheumatism·2017
Same author

APhA2017 House of Delegates: Opportunities for collaboration: Moving forward through meaningful involvement and engagement.

Journal of the American Pharmacists Association : JAPhA·2017

Related Experiment Video

Updated: Apr 24, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

20.2K

Schizophrenia: overview and treatment options.

Krishna R Patel, Jessica Cherian, Kunj Gohil

    P & T : a Peer-Reviewed Journal for Formulary Management
    |September 12, 2014
    PubMed
    Summary

    Schizophrenia is a complex brain disorder with diverse symptoms. This symptom variability hinders consensus on diagnosis, causes, and treatments, complicating effective therapeutic strategies.

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Genetics

    Background:

    • Schizophrenia presents as a complex psychiatric disorder with significant symptom heterogeneity.
    • This variability complicates establishing diagnostic consensus, understanding etiology, and identifying pathophysiology.
    • The lack of unified understanding impedes the development of effective therapeutic interventions.

    Purpose of the Study:

    • To explore the multifaceted nature of schizophrenia.
    • To address the challenges posed by symptom heterogeneity in schizophrenia research.
    • To provide a foundation for future research into diagnostic criteria, etiology, and pathophysiology.

    Main Methods:

    • Literature review of existing schizophrenia research.
    • Analysis of symptom clusters and their implications.

    More Related Videos

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
    07:31

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

    Published on: May 15, 2020

    8.3K
    Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
    12:00

    Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization

    Published on: November 19, 2014

    14.2K

    Related Experiment Videos

    Last Updated: Apr 24, 2026

    Development of a Virtual Reality Assessment of Everyday Living Skills
    10:32

    Development of a Virtual Reality Assessment of Everyday Living Skills

    Published on: April 23, 2014

    20.2K
    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
    07:31

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

    Published on: May 15, 2020

    8.3K
    Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
    12:00

    Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization

    Published on: November 19, 2014

    14.2K
  • Comparative study of diagnostic and etiological models.

    • Main Results:

    • Identified significant challenges in schizophrenia diagnosis due to symptom diversity.
    • Highlighted the complex interplay of genetic and environmental factors in schizophrenia etiology.
    • Demonstrated the need for refined pathophysiological models.

    Conclusions:

    • Schizophrenia's heterogeneity is a primary obstacle to diagnostic and therapeutic advancement.
    • Further research is required to delineate distinct subtypes and underlying mechanisms.
    • Developing targeted treatments necessitates a deeper understanding of schizophrenia's complex pathophysiology.